JP2015527341A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015527341A5 JP2015527341A5 JP2015525570A JP2015525570A JP2015527341A5 JP 2015527341 A5 JP2015527341 A5 JP 2015527341A5 JP 2015525570 A JP2015525570 A JP 2015525570A JP 2015525570 A JP2015525570 A JP 2015525570A JP 2015527341 A5 JP2015527341 A5 JP 2015527341A5
- Authority
- JP
- Japan
- Prior art keywords
- lung cancer
- histology
- cetuximab
- determining
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012079399 | 2012-07-31 | ||
| CNPCT/CN2012/079399 | 2012-07-31 | ||
| PCT/US2013/053091 WO2014028221A1 (en) | 2012-07-31 | 2013-07-31 | Histological markers for identifying non-small cell lung carcinoma patients for treatment with an anti-egfr drug |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015527341A JP2015527341A (ja) | 2015-09-17 |
| JP2015527341A5 true JP2015527341A5 (enExample) | 2016-07-07 |
| JP6324381B2 JP6324381B2 (ja) | 2018-05-16 |
Family
ID=50101405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015525570A Expired - Fee Related JP6324381B2 (ja) | 2012-07-31 | 2013-07-31 | 抗ｅｇｆｒ薬物による処置のための非小細胞肺癌患者を同定するための組織学的マーカー |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9921222B2 (enExample) |
| EP (1) | EP2879712B1 (enExample) |
| JP (1) | JP6324381B2 (enExample) |
| ES (1) | ES2668861T3 (enExample) |
| WO (1) | WO2014028221A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2017003304A (es) * | 2014-09-16 | 2017-08-15 | Abbvie Inc | Veliparib en combinacion con carboplatino y paclitaxel para el tratamiento de cancer de pulmon de celulas no pequeñas en fumadores. |
| TWI859118B (zh) | 2017-03-29 | 2024-10-21 | 大陸商中美冠科生物技術（太倉）有限公司 | 測定對胃癌之西妥昔單抗（ｃｅｔｕｘｉｍａｂ）敏感性的系統及方法 |
| CN112813164A (zh) * | 2021-01-18 | 2021-05-18 | 四川省肿瘤医院 | Ereg促进nsclc细胞对egfr-tki产生耐药性原因的验证方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4128089A (en) | 1988-09-15 | 1990-03-22 | Rorer International (Overseas) Inc. | Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same |
| US5942602A (en) | 1997-02-13 | 1999-08-24 | Schering Aktiengessellschaft | Growth factor receptor antibodies |
| US6949245B1 (en) | 1999-06-25 | 2005-09-27 | Genentech, Inc. | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| PL202369B1 (pl) | 1999-08-27 | 2009-06-30 | Genentech Inc | Zastosowanie przeciwciała skierowanego przeciw ErbB2, zastosowanie przeciwciała skierowanego przeciw ErbB oraz zestaw zawierający to przeciwciało |
| EP1622941A2 (en) | 2003-03-20 | 2006-02-08 | ImClone Systems Incorporated | Method of producing an antibody to epidermal growth factor receptor |
| WO2005090407A1 (en) | 2004-03-19 | 2005-09-29 | Imclone Systems Incorporated | Human anti-epidermal growth factor receptor antibody |
| EP1913157B2 (en) | 2005-06-28 | 2016-10-26 | Genentech, Inc. | Egfr and kras mutations for prediction of patient response to egfr inhibitor treatment |
| ATE461220T1 (de) | 2005-11-12 | 2010-04-15 | Lilly Co Eli | Anti-egfr-antikörper |
| EP2091975A4 (en) | 2006-11-21 | 2013-05-22 | Univ California | ANTIBODIES TO THE EGFR FAMILY, BICE-SPECIFIC ANTIBODIES TO THE EGFR FAMILY AND METHOD FOR THEIR USE |
| US7977336B2 (en) | 2006-12-28 | 2011-07-12 | Banyu Pharmaceutical Co. Ltd | Aminopyrimidine derivatives as PLK1 inhibitors |
| KR100968591B1 (ko) | 2007-06-14 | 2010-07-08 | 한국과학기술연구원 | 약물전달용 폴리포스파젠계 하이드로젤, 그의 제조방법 및그의 용도 |
| US20100009390A1 (en) | 2008-05-09 | 2010-01-14 | The Regents Of The University Of California | Mutant antibodies with high affinity for egfr |
| PE20110926A1 (es) | 2008-09-26 | 2011-12-29 | Roche Glycart Ag | Anticuerpos biespecificos anti-egfr/anti-igf-1r |
| WO2010080463A1 (en) | 2008-12-18 | 2010-07-15 | Imclone Llc | Antibody humanization |
| KR101108642B1 (ko) | 2009-09-29 | 2012-02-09 | 주식회사 녹십자 | 표피 성장 인자 수용체에 특이적으로 결합하는 항체 |
| EP2493929B1 (en) | 2009-10-28 | 2017-08-16 | AbbVie Biotherapeutics Inc. | Anti-egfr antibodies and their uses |
| CN102713606A (zh) | 2009-11-13 | 2012-10-03 | 无限制药股份有限公司 | 用于鉴定、评估、预防和治疗癌症的组合物、试剂盒和方法 |
| CN102686241A (zh) | 2009-12-29 | 2012-09-19 | 霍夫曼-拉罗奇有限公司 | 抗体配制剂 |
| JP2011144124A (ja) | 2010-01-13 | 2011-07-28 | Fujirebio Inc | 活性型ｅｇｆｒ特異抗体 |
| CA2798273A1 (en) | 2010-05-04 | 2011-11-10 | Merrimack Pharmaceuticals, Inc. | Antibodies against epidermal growth factor receptor (egfr) and uses thereof |
| WO2011140151A1 (en) | 2010-05-04 | 2011-11-10 | Dyax Corp. | Antibodies against epidermal growth factor receptor (egfr) |
| US9029513B2 (en) | 2010-06-04 | 2015-05-12 | Toagosei Co. Ltd. | Anti-EGFR antibody and use thereof |
| WO2011156617A2 (en) | 2010-06-09 | 2011-12-15 | Aveo Pharmaceuticals, Inc. | Anti-egfr antibodies |
| WO2012020059A1 (en) | 2010-08-10 | 2012-02-16 | Glycotope Gmbh | Humanized egfr antibodies |
| US9155802B2 (en) | 2010-11-01 | 2015-10-13 | Symphogen A/S | Pan-HER antibody composition |
| US8691231B2 (en) | 2011-06-03 | 2014-04-08 | Merrimack Pharmaceuticals, Inc. | Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies |
-
2013
- 2013-07-31 EP EP13829184.4A patent/EP2879712B1/en active Active
- 2013-07-31 WO PCT/US2013/053091 patent/WO2014028221A1/en not_active Ceased
- 2013-07-31 US US14/418,684 patent/US9921222B2/en not_active Expired - Fee Related
- 2013-07-31 JP JP2015525570A patent/JP6324381B2/ja not_active Expired - Fee Related
- 2013-07-31 ES ES13829184.4T patent/ES2668861T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Singh et al. | TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy | |
| Tsimberidou et al. | Precision cancer medicine: the future is now, only better | |
| Aggarwal et al. | Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy | |
| JP2014514278A5 (enExample) | ||
| WO2010145796A3 (en) | Biomarkers and methods for determining efficacy of anti-egfr antibodies in cancer therapy | |
| JOP20140128B1 (ar) | تركيبة علاجية تشتمل على مثبط b_raf ومثبط ثان | |
| WO2018183817A3 (en) | Tumor burden as measured by cell free dna | |
| JP2015505959A5 (enExample) | ||
| JP2015210268A5 (enExample) | ||
| JP2016515141A5 (enExample) | ||
| Habib et al. | Bevacizumab and weekly paclitaxel for non-squamous non small cell lung cancer patients: a retrospective study | |
| Quaquarini et al. | Prognostic and predictive roles of HER2 status in non-breast and non-gastroesophageal carcinomas | |
| Kotake et al. | Multicenter phase II study of infusional 5‑fluorouracil (5‑FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first‑line treatment in patients with metastatic colorectal cancer (CELINE trial) | |
| Shao et al. | Use and misuse of waterfall plots | |
| Lee et al. | Composition of inflammatory cells regulating the response to concurrent chemoradiation therapy for HPV (+) tonsil cancer | |
| JP2019519772A (ja) | Ｈｅｒ２及びｈｅｒ３の経路サブタイピングに基づく乳癌患者の薬物療法の選択方法 | |
| WO2014023808A3 (en) | Method for evaluating a cancer patient for propensity to respond to a therapy | |
| WO2016161153A3 (en) | Prognostic and diagnostic methods for colorectal cancer | |
| Beiki | Prognostic value of lymph node ratios in node positive rectal cancer treated with preoperative chemoradiation | |
| Hyung et al. | Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis | |
| Yang et al. | Handbook of therapeutic biomarkers in cancer | |
| JP6324381B2 (ja) | 抗ｅｇｆｒ薬物による処置のための非小細胞肺癌患者を同定するための組織学的マーカー | |
| Sidaway | WEE1 kinase inhibitor shows promise | |
| Killock | Personalized MRD assays and therapy? | |
| Hirsch et al. | Quality of Care of Patients With Non–Small-Cell Lung Cancer: A Report of a Performance Improvement Initiative |